세계의 의료기기 상환 시장 : 규모, 점유율 및 동향 분석(청구별, 지불자별, 서비스 제공업체별, 지역별), 부문별 예측(2025-2030년)

Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Claim (Underpaid, Full Paid), By Payer (Public, Private), By Service Provider (Hospitals), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,242,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,627,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,398,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

세계의 의료기기 상환 시장 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 의료기기 상환 시장 규모는 2030년까지 1조 1,717억 2,000만 달러에 달하고, 2025년부터 2030년까지 CAGR 7.07%로 확대될 것으로 예측되고 있습니다. 의료기기 상환이란 의료기기 사용중에 발생한 비용에 대해 제3자인 민간 또는 공공 보험자가 의료 제공업체에게 지불하는 지불로 정의됩니다. 산업의 성장을 가속하는 주요 요인은 상환에 대한 의존도 증가, 만성 질환의 유병률 증가, 예방 의료의 확대입니다.

예를 들어 유방암 검진의 철저 등 진료 보상을 통해 조기 진단에 인센티브를 주는 기본적인 패러다임 시프트가 신흥국 전체에서 주목받고 있습니다. 그러나 유행의 회복기에는 일본이나 중국과 같은 국가들이 수술의 정확성을 향상시키기 위해 로봇 지원 제공업체에게 상환 제공에 적극적으로 관여하고 있기 때문에 특히 아시아태평양에서는 이러한 수술이 개선 될 것으로 예측됩니다. 이러한 이니셔티브는 유통 후 시장 성장에 좋은 영향을 미칠 가능성이 높습니다.

북미는 2024년 수익 점유율 45.71% 이상으로 시장을 독점하고 있으며, 예측 기간 동안에도 그 우위성을 유지할 것으로 예측됩니다. 예를 들어, 2022년 1월 Science Direct에 게재된 연구에 따르면 2011년부터 2021년 사이에 영상 진단 검사에 대한 진료 보상은 꾸준히 감소하고 있습니다.

의료기기 상환 시장 : 분석 개요

• 민간 지불자 부문은 시장에 다수의 민간 기업이 존재하기 때문에 예측 기간 중에 가장 빠른 CAGR로 성장할 것으로 예측됩니다.
• 의료 환경별로는 병원이 최근의 기술 동향과 의료기기의 사용을 필요로 하는 환자수가 많기 때문에 예측기간 중에 가장 빠른 CAGR로 성장할 것으로 예측됩니다.
• 아시아태평양은 농촌와 도시에서 보험서비스의 보급률 상승으로 예측기간 중에 급성장이 보일 것으로 예측되고 있습니다.

목차

제1장 분석 방법 및 범위

제2장 주요 요약

제3장 시장의 변동 요인, 경향, 범위

• 시장 연관 전망
  • 상위 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 분석 도구
  • 의료기기 상환 : Porter's Five Forces 분석
  • 의료기기 상환 : PESTEL 분석

제4장 의료기기 상환 시장 : 청구별 추정 및 동향 분석

• 의료기기 상환 시장 : 청구별 대시보드
• 동향과 시장 점유율 분석 : 청구별(2024년 및 2030년)
• 의료기기 상환 시장 규모와 예측 : 청구별(2018-2030년)
• 부분 상환
  • 부분 상환 시장(2018-2030년)
• 전액 상환
  • 전액 상환 시장(2018-2030년)

제5장 의료기기 상환 시장 : 지불자별 추정 및 동향 분석

• 의료기기 상환 시장 : 지불자별 대시보드
• 동향과 시장 점유율 분석 : 지불자별(2024년 및 2030년)
• 의료기기 상환 시장 규모와 예측 : 지불자별(2018-2030년)
• 공공
  • 공공 시장(2018-2030년)
• 민간
  • 민간 시장(2018-2030년)

제6장 의료기기 상환 시장 : 서비스 제공업체별 추정 및 동향 분석

• 의료기기 상환 시장 : 서비스 제공업체별 대시보드
• 동향과 시장 점유율 분석 : 서비스 제공업체별(2024년 및 2030년)
• 의료기기 상환 시장 규모와 예측 : 서비스 제공업체별(2018-2030년)
• 병원
  • 병원 시장(2018-2030년)
• 개업의
  • 개업의 시장(2018-2030년)
• 진단실험실
  • 진단실험실 시장(2018-2030년)
• 기타
  • 기타 시장(2018-2030년)

제7장 의료기기 상환 시장 : 지역별 분석

• 지역별 전망
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제8장 경쟁 분석

• 기업 분류
• 기업 시장 포지션 분석
• 전략 매핑
• 기업 프로파일/상장 기업
  • CRA(IQVIA)
  • WellCare Health Plans, Inc.
  • BNP Paribas
  • Boston Scientific
  • Humana
  • Cigna Healthcare
  • Anthem Insurance Companies, Inc.(Elevance Health)
  • Abbott Laboratories
  • Ethicon(J&J Medtech)
  • AdvaMed

JHS

영문 목차

영문목차

Medical Devices Reimbursement Market Growth & Trends:

The global medical devices reimbursement market size is expected to reach USD 1,171.72 billion by 2030, expanding at a CAGR of 7.07% from 2025 to 2030, according to a new report by Grand View Research, Inc. Medical device reimbursement is defined as the payment a third-party private or public insurer pays a healthcare provider for the cost incurred while using medical equipment. The major factors fueling the industry growth are growing dependence on reimbursement, the increasing prevalence of chronic diseases, and growing preventive care. Focus on early diagnostics and preventive care may in turn lead to higher activity within the diagnostic device industry, thus promoting more reimbursement share from them.

For instance, a fundamental paradigm shift towards incentivizing early diagnosis through reimbursement has been noticed across developed economies, such as thorough screening for breast cancer. During the COVID-19 pandemic, surgeries such as robotic-assisted procedures were postponed. However, during the pandemic recovery period, these surgeries are expected to improve particularly in Asia pacific as the countries such as Japan and China are actively involved in providing reimbursement to robotic-assisted providers to improve the accuracy of surgeries. Such initiatives are likely to have a positive impact on market growth in the post-pandemic period. With an increasing demand for medical equipment, reimbursement services are expected to provide various opportunities for healthcare industries to poach upon. Additionally, the increasing number of people pursuing insurance and consolidation of the healthcare system are major factors fueling the industry growth.

North America dominated the market with a revenue share of over 45.71% in 2024 and is expected to maintain its dominance over the forecast period. The rising demand for healthcare equipment and the increasing number of healthcare centers are expected to drive the industry in this region. The growing prevalence of chronic diseases is driving the demand for various healthcare instruments. This is further expected to support the growth of the regional market. Over the years, the Centers for Medicare & Medicaid Services have reduced the reimbursement for diagnostic radiology in the U.S. For instance, in January 2022, a study published in Science Direct stated that, between 2011 - 2021, there was a steady decline in the reimbursement for diagnostic imaging studies. A continuation of this trend by the government agencies is expected to have a negative impact on the regional market growth in the post-pandemic period.

Medical Devices Reimbursement Market Report Highlights:

• The private payer segment is expected to grow at the fastest CAGR over the forecast period owing to the presence of a large number of private players in the market.
• By healthcare setting, the hospitals are expected to grow at the fastest CAGR over the forecast period to recent technological developments and high patient footfall requiring the use of healthcare instruments.
• Asia Pacific is projected to witness rapid growth during the forecast period owing to the rising penetration of insurance services in rural and urban areas.

Table of Contents

Chapter 1 Methodology And Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Segment Definitions
    • 1.1.1.1 By Claim
    • 1.1.1.2 By Payers
    • 1.1.1.3 By Service Provider
  • 1.1.2 Estimates And Forecast Timeline
• 1.2 Research Methodology
  • 1.2.1 Model Details
    • 1.2.1.1 Medical Devices Reimbursement Market Size Estimation
    • 1.2.1.2 Forecasting Methodology
    • 1.2.1.3 Region- & Country-Based Segment Share Calculation
    • 1.2.1.4 Medical Devices Reimbursement Market: Cagr Calculation
  • 1.2.2 Information Procurement
    • 1.2.2.1 Purchased Database
    • 1.2.2.2 GVR's Internal Database
    • 1.2.2.3 Primary Research
      • 1.2.2.3.1 Details Of The Primary Research
• 1.3 Information Or Data Analysis
  • 1.3.1 Data Analysis Models
• 1.4 Market Formulation & Validation
• 1.5 List Of Secondary Sources
• 1.6 List Of Abbreviations
• 1.7 Objectives
  • 1.7.1 Objective - 1
  • 1.7.2 Objective - 2
  • 1.7.3 Objective - 3

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Outlook
• 2.3 Competitive Landscape

Chapter 3 Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Increasing Prevalence Of Various Chronic Diseases
    • 3.2.1.2 Growing Adoption Of Value-Based Healthcare Models
    • 3.2.1.3 Regulatory Policies Supporting Reimbursement Expansion
    • 3.2.1.4 Technological Advancements In Medical Devices
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 Complex Framework
• 3.3 Business Analysis Tools
  • 3.3.1 Medical Devices Reimbursement - Porter's Five Forces Analysis
  • 3.3.2 Medical Devices Reimbursement - Pestle Analysis

Chapter 4 Medical Devices Reimbursement Market: Claim Estimates & Trend Analysis

• 4.1 Medical Devices Reimbursement Market Claim Segment Dashboard
• 4.2 Claim Movement & Market Share Analysis, 2024 & 2030
• 4.3 Medical Devices Reimbursement Market Size & Forecast And Forecasts, By Claim, 2018-2030 (USD Billion)
• 4.4 Underpaid r
  • 4.4.1 Underpaid Market, 2018 - 2030 (USD Billion)
• 4.5 Full paid r
  • 4.5.1 Full paid Market, 2018 - 2030 (USD Billion)

Chapter 5 Medical Devices Reimbursement Market: Payer Estimates & Trend Analysis

• 5.1 Medical Devices Reimbursement Market Payer Segment Dashboard
• 5.2 Payer Movement & Market Share Analysis, 2024 & 2030
• 5.3 Medical Devices Reimbursement Market Size & Forecast And Forecasts, By Payer, 2018-2030 (USD Billion)
• 5.4 Public
  • 5.4.1 Public Market, 2018 - 2030 (USD Billion)
• 5.4 Private
  • 5.4.1 Private Market, 2018 - 2030 (USD Billion)

Chapter 6 Medical Devices Reimbursement Market: Service Provider Estimates & Trend Analysis

• 6.1 Medical Devices Reimbursement Market: Service Provider Segment Dashboard
• 6.2 Service Provider Movement & Market Share Analysis, 2024 & 2030
• 6.3 Medical Devices Reimbursement Market Size & Forecast And Forecasts, By Service Provider (USD Billion)
• 6.4 Hospitals
  • 6.4.1 Hopspitals Market, 2018 - 2030 (USD Billion)
• 6.5 Physician Offices
  • 6.5.1 Physician Offices Market, 2018 - 2030 (USD Billion)
• 6.6 Diagnostic Laboratories
  • 6.6.1 Diagnostic Laboratories Market, 2018 - 2030 (USD Billion)
• 6.7 Others
  • 6.7.1 Others Market, 2018 - 2030 (USD Billion)

Chapter 7 Medical Devices Reimbursement Market: Regional Analysis

• 7.1 Regional Outlook
• 7.2 North America
  • 7.2.1 North America Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion).
  • 7.2.2 U.S.
    • 7.2.2.1 Key Country Dynamics
    • 7.2.2.2 U.S. Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.2.3 Canada
    • 7.2.3.1 Key Country Dynamics
    • 7.2.3.2 Canada Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.2.4 Mexico
    • 7.2.4.1 Key Country Dynamics
    • 7.2.4.2 Mexico Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
• 7.3 Europe
  • 7.3.1 Europe Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.2 Germany
    • 7.3.2.1 Key Country Dynamics
    • 7.3.2.2 Germany Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.3 Uk
    • 7.3.3.1 Key Country Dynamics
    • 7.3.3.2 Uk Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.4 France
    • 7.3.4.1 Key Country Dynamics
    • 7.3.4.2 France Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.5 Italy
    • 7.3.5.1 Key Country Dynamics
    • 7.3.5.2 Italy Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.6 Spain
    • 7.3.6.1 Key Country Dynamics
    • 7.3.6.2 Spain Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.7 Sweden
    • 7.3.7.1 Key Country Dynamics
    • 7.3.7.2 Sweden Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.8 Norway
    • 7.3.8.1 Key Country Dynamics
    • 7.3.8.2 Norway Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.9 Denmark
    • 7.3.9.1 Key Country Dynamics
    • 7.3.9.2 Denmark Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
• 7.4 Asia Pacific
  • 7.4.1 Asia Pacific Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.4.2 Japan
    • 7.4.2.1 Key Country Dynamics
    • 7.4.2.2 Japan Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion).
  • 7.4.3 China
    • 7.4.3.1 Key Country Dynamics
    • 7.4.3.2 China Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.4.5 India
    • 7.4.5.1 Key Country Dynamics
    • 7.4.5.2 India Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.4.6 Australia
    • 7.4.6.1 Key Country Dynamics
    • 7.4.6.2 Australia Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.4.7 South Korea
    • 7.4.7.1 Key Country Dynamics
    • 7.4.7.2 South Korea Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.4.8 Thailand
    • 7.4.8.1 Key Country Dynamics
    • 7.4.8.2 Thailand Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
• 7.5 Latin America
  • 7.5.1 Latin America Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.5.2 Brazil
    • 7.5.2.1 Key Country Dynamics
    • 7.5.2.2 Brazil Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.5.3 Argentina
    • 7.5.3.1 Key Country Dynamics
    • 7.5.3.2 Argentina Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
• 7.6 Middle East & Africa
  • 7.6.1 Middle East & Africa Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.6.2 South Africa
    • 7.6.2.1 Key Country Dynamics
    • 7.6.2.2 South Africa Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.6.3 Saudi Arabia
    • 7.6.3.1 Key Country Dynamics
    • 7.6.3.2 Saudi Arabia Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.6.4 UAE
    • 7.6.4.1 Key Country Dynamics
    • 7.6.4.2 Uae Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.6.5 Kuwait
    • 7.6.5.1 Key Country Dynamics
    • 7.6.5.2 Kuwait Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)

Chapter 8 Competitive Analysis

• 8.1. Company Categorization
• 8.2. Company Market Position Analysis
• 8.3. Strategy Mapping
• 8.4. Company Profiles/Listing
  • 8.4.1. CRA (IQVIA)
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Service Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. WellCare Health Plans, Inc.
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Service Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. BNP Paribas
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Service Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Boston Scientific
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Service Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Humana
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Service Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Cigna Healthcare
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Service Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Anthem Insurance Companies, Inc. (Elevance Health)
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Service Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Abbott Laboratories
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Service Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Ethicon (J & J Medtech)
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Service Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. AdvaMed
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Service Benchmarking
    • 8.4.10.4. Strategic Initiatives

관련자료